Menu Close

Trending

Novartis reports two liver-related deaths with Zolgensma
New horizons in breast cancer care
Why reshoring drug production means embracing continuous manufacturing
Clariness, DailyBreath partner to drive recruitment in asthma trials
J&J says it will stop selling all talc products next year

Views & Analysis

kidney

Oncology/ Patients/ R&D/ Views & Analysis/ Views & Analysis/ Views & Analysis/ Views and analysis

Putting patient perspectives at the heart of kidney cancer research

, , , , , , 0 Comment

Commissioned by Ipsen. Ipsen’s Steven Hildemann looks at how we can harness the power of patient perspectives in

X
Putting patient perspectives at the heart of kidney cancer research
https://pharmaphorum.com/patients/patient-perspectives-kidney-cancer-research/
Regulation optimisation could save thousands of life years

Market Access/ Oncology/ Patients/ Views & Analysis/ Views & Analysis/ Views & Analysis/ Views and analysis

Regulation optimisation could save thousands of life years

, , , 0 Comment

Embracing a “once-in-a-generation opportunity” to improve access to oncology treatments could save thousands of years of life across

X
Regulation optimisation could save thousands of life years
https://pharmaphorum.com/oncology/regulation-optimisation-save-thousands-life-years/
 
943-Cerner-Enviza-Webinar-Image-1200x675-Text-NEW2

Oncology/ Views & Analysis/ Views and analysis/ Webinars/ Webinars in home page/ Webinars On demand

Oncology treatment decisions aren’t just based on clinical data

, , , 0 Comment

Once widely acknowledged as so special that only scientists and clinical specialists need to apply, oncology has become

X
Oncology treatment decisions aren’t just based on clinical data
https://pharmaphorum.com/webinars/oncology-treatment-decisions-arent-just-based-on-clinical-data/
Crowd of adult citizens walking on city street - New reality lifestyle concept with senior people with covered faces - Selective focus on bearded man with blue protective mask

Oncology/ Views & Analysis/ Views and analysis

Blood Cancer UK: Hopes for our community’s future in the time of COVID

, , , , , 0 Comment

This thought leadership series has been paid and developed by Kite, a Gilead Company. This Blood Cancer Awareness

X
Blood Cancer UK: Hopes for our community’s future in the time of COVID
https://pharmaphorum.com/oncology/blood-cancer-uk-hopes-for-our-communitys-future-in-the-time-of-covid/
How pharma can help the post-COVID recovery of European cancer care

Oncology/ Views & Analysis/ Views and analysis/ White Papers/ Whitepapers

How pharma can help the post-COVID recovery of European cancer care

, , , 0 Comment

The new Cancer Care in Europe: Recovering from COVID-19 Disruption white paper assesses the disruption to patient care and

X
How pharma can help the post-COVID recovery of European cancer care
https://pharmaphorum.com/whitepapers/pharma-covid-recovery-cancer-care/
scotland-1166192_1280

Market Access/ Oncology/ Views & Analysis/ Views & Analysis/ Views and analysis

Collaborate to simplify cancer trials and accelerate post-pandemic recovery

, , , 0 Comment

How could simplifying the administration of clinical trials help cancer diagnosis, care, and treatment levels to exceed pre-pandemic

X
Collaborate to simplify cancer trials and accelerate post-pandemic recovery
https://pharmaphorum.com/views-and-analysis/collaborate-to-simplify-cancer-trials-and-accelerate-post-pandemic-recovery/
«‹ 2 3 4 5 ›»

Login

CONTINUE TO SITE >
X
Close in 10 seconds